CSL NEW ZEALAND MONOFIX-VF dried Factor IX (Human) powder for injection

Land: Australië

Taal: Engels

Bron: Department of Health (Therapeutic Goods Administration)

Werkstoffen:

Factor IX, Quantity: 500 IU

Beschikbaar vanaf:

CSL Behring Australia Pty Ltd

farmaceutische vorm:

Injection, diluent for

Samenstelling:

Excipient Ingredients: water for injections

Toedieningsweg:

Intravenous

Eenheden in pakket:

500 IU

Prescription-type:

(S1) This Schedule is intentionally blank

therapeutische indicaties:

MonoFIX-VF is indicated for the treatment of haemorrhages, for use in surgery, and as prophylaxis in patients with haemophilia B. MonoFIX-VF is not indicated for the treatment of Factor II, VII or X deficiencies because it does not contain therapeutic levels of these coagulation factors. MonoFIX-VF is not indicated for the treatment of haemophilia A patients with Factor VIII inhibitors.

Product samenvatting:

Visual Identification: Clear,colourless solution free from visible particles; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Autorisatie-status:

Listed (Export Only)

Autorisatie datum:

1998-06-05